$CLS

MIONIS ROBERT sold $26.4M of CLS (indirect holdings)

MIONIS ROBERT (Chief Executive Officer) sold 66,056 indirectly-held shares of CELESTICA INC (CLS) at an average of $400.06 ($394.58–$413.68, $26.43M total) across 17 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MIONIS ROBERT
Published Jun 18, 2026, 12:53 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
medium confidence
Mentioned
$CLS
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

The disclosure provides a concrete, time-stamped insider selling event (66,056 shares; ~$26.4M) that can influence short-term sentiment, though 10b5-1 lowers interpretive value.

02

Market read

A sizable CEO sale in CLS is newly disclosed, but the pre-arranged nature suggests limited fundamental information content.

03

What to watch

Traders may over-weight insider sales; without accompanying guidance, contract, or earnings changes, the signal is typically weak.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-17 for a sale executed 2026-06-15

Background

SEC Form 4 reports an insider transaction by Celestica CEO Mionis Robert, executed as an open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$CLSNeutralMedium confidence
Context

Celestica CEO Mionis Robert sold $26.4M of CLS shares via a Rule 10b5-1 plan, with 66,056 shares sold at ~$394.58–$413.68 on 2026-06-15.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless accompanied by other fundamental news.

Evidence & confidence

Form 4 confirms transaction size and timing, but 10b5-1 reduces signaling value versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • Celestica Inc

    Subject of the Form 4 insider sale; CEO sold shares totaling ~$26.4M.

  • Mionis Robert

    CEO and officer/director who executed the sale under a pre-arranged 10b5-1 plan.

Related articles

$CLSMedAI 8/10

Celestica Completes Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) said it completed its equity offering of 9,677,419 common shares at $310 per share. Including the underwriters’ option, 11,129,031 shares were sold for about $3.45 billion in gross proceeds. Net proceeds will be used for working capital, capital expenditures, and general corporate purposes.

$CLSHighAI 9/10

Celestica Falls After Pricing $3 Bln Equity Offering

Celestica Inc. (CLS) shares fell nearly 12% after the company priced a $3.0 billion public equity offering. According to the company, it sold 9.68 million common shares at $310 each, raising expected gross proceeds of $3.0 billion, and gave underwriters a 30-day option for up to 1.45 million additional shares. CLS traded around $319.48, down about $43.28.

$CLSHighAI 9/10

Why is Celestica stock sliding today?

Celestica (CLS) shares fell 13.7% after the company priced a $3 billion common stock offering at $310 per share, down from the prior close of $362.76. Celestica plans to sell about 9.68 million treasury shares, with underwriters able to buy 1.45 million more. Management said the raise supports AI compute and networking demand.

$CLSMedAI 8/10

Celestica Announces Pricing of Equity Offering

Celestica Inc. (NYSE: CLS, TSX: CLS) priced an equity offering of 9,677,419 common shares at $310 per share. Gross proceeds are expected at about $3.0 billion before underwriting discounts and expenses. Underwriters have a 30-day option to buy up to 1,451,612 additional shares. Net proceeds will fund working capital and capital expenditures, among other purposes. Closing is expected around Aug. 7, 2026.